According to experts, TB remains the top infectious killer in the world claiming over 4,000 lives a day.

NEW DELHI

18 October 2019 00:00 IST

Number of patients fall by almost 50,000 over past year, says WHO report

The tuberculosis incidence rate in India has decreased by almost 50,000 patients over the past one year, according to the World Health Organization (WHO)-2019 edition of the Global Tuberculosis (TB) Report released on Thursday.

The report notes that in 2017, India had 27.4 lakh TB patients which came down to 26.9 lakh in 2018. Incidence per 1,00,000 population has decreased from 204 in 2017 to 199 in 2018. The number of patients being tested for rifampicin resistance has increased from 32% in 2017 to 46% in 2018. And the treatment success rate has increased to 81% for new and relapse cases (drug sensitive) in 2017, which was 69% in 2016.

Advertising

Advertising

The report provides a comprehensive and up-to-date assessment of the TB epidemic and progress in the response at global, regional and country levels for India.

Disease trends

It also features data on disease trends and the response to the epidemic in 202 countries and territories. “This includes trends in TB incidence and mortality, data on case detection and treatment results for TB, multidrug-resistant TB (MDR-TB), TB/HIV, TB prevention, universal health coverage as well as financing,” noted the report.

According to experts, TB remains the top infectious killer in the world claiming over 4,000 lives a day. This report presents progress towards targets set at the first-ever United Nations General Assembly high-level meeting on TB in 2018, that brought together heads of state, as well as the targets of the WHO End TB Strategy and Sustainable Development Goals.

Covering all cases

Meanwhile, the India TB-Report 2019 notes that India is closest ever to covering all TB cases through the online notification system (NIKSHAY). “With the aim of universal access to free diagnostics and treatment services, state-of-the-art diagnostic tests and quality assured drugs have been extended to all patients seeking TB care,” notes the India report.

In India, of the estimated 2.69 million TB cases emerging in 2018, 2.15 million were reported to the Government of India — leaving a gap of 5,40,000 patients who are going unreported.